T2CANDIDA Trademark

Trademark Overview


On Friday, July 19, 2013, a trademark application was filed for T2CANDIDA with the United States Patent and Trademark Office. The USPTO has given the T2CANDIDA trademark a serial number of 86014788. The federal status of this trademark filing is REGISTERED AND RENEWED as of Monday, June 24, 2024. This trademark is owned by T2 Biosystems, Inc.. The T2CANDIDA trademark is filed in the Pharmaceutical Products category with the following description:

Diagnostic reagents for identification and analysis of Candida fungal infections for medical use, medical diagnostic assays for testing biological fluids for Candida fungal infections; assays for use in medical and clinical diagnostics of Candida fungal infections
t2candida

General Information


Serial Number86014788
Word MarkT2CANDIDA
Filing DateFriday, July 19, 2013
Status800 - REGISTERED AND RENEWED
Status DateMonday, June 24, 2024
Registration Number4501051
Registration DateTuesday, March 25, 2014
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 7, 2014

Trademark Statements


Goods and ServicesDiagnostic reagents for identification and analysis of Candida fungal infections for medical use, medical diagnostic assays for testing biological fluids for Candida fungal infections; assays for use in medical and clinical diagnostics of Candida fungal infections
Pseudo MarkT TWO CANDIDA; T TO CANDIDA

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 25, 2013
Primary Code005
First Use Anywhere DateTuesday, December 11, 2012
First Use In Commerce DateTuesday, December 11, 2012

Trademark Owner History


Party NameT2 Biosystems, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressLexington, MA 02421

Party NameT2 Biosystems, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLexington, MA 02421

Party NameT2 Biosystems, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLexington, MA 02421

Trademark Events


Event DateEvent Description
Tuesday, July 23, 2013NEW APPLICATION ENTERED
Thursday, July 25, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 26, 2013NOTICE OF PSEUDO MARK E-MAILED
Thursday, December 5, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, December 18, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 7, 2014PUBLISHED FOR OPPOSITION
Saturday, November 2, 2013ASSIGNED TO EXAMINER
Friday, November 8, 2013EXAMINERS AMENDMENT -WRITTEN
Friday, November 8, 2013EXAMINERS AMENDMENT E-MAILED
Friday, November 8, 2013NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, November 8, 2013EXAMINER'S AMENDMENT ENTERED
Friday, November 8, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, December 5, 2013ASSIGNED TO LIE
Tuesday, March 25, 2014REGISTERED-PRINCIPAL REGISTER
Monday, March 25, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, May 14, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, May 14, 2019REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, January 7, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, April 3, 2019TEAS SECTION 8 & 15 RECEIVED
Tuesday, May 14, 2019NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Saturday, March 25, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, March 22, 2024TEAS SECTION 8 & 9 RECEIVED
Monday, June 24, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, June 24, 2024REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Monday, June 24, 2024REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Monday, June 24, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED